ArticleBrain and behavior2026
Causal Associations of Cerebrospinal Fluid and Circulating Metabolites With Malignant Brain Neoplasms: A Mendelian Randomization Analysis.
Article in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundEmerging insights from immunometabolism underscore the importance of metabolic-immune interactions in shaping the brain tumor microenvironment and potentially influencing brain behavior and neurological outcomes. Although previous studies have suggested potential links between metabolites and risks of malignant brain tumor development, the causal relationship remains unclarified.
methodsExposures were extracted from 136,016 Europeans for 233 circulating metabolites and from 689 participants for 338 cerebrospinal fluid (CSF) metabolite levels. Genome-wide association study (GWAS) data for malignant neoplasm of the brain (NCase = 1070, NControl = 345,118) from the FinnGen consortium were used. The primary univariable Mendelian randomization (UVMR) analysis used inverse variance weighting (IVW) and three additional methods for causal assessment. Multivariable MR (MVMR) assessed the direct effects of metabolites, and suggestive biomarkers underwent metabolic pathway enrichment.
resultsTwelve metabolic pathways and 21 metabolites (4 circulating biomarkers and 17 CSF metabolites) potentially linked to brain malignancy. The strongest associations were observed for the ratio of omega-3 fatty acids to total fatty acids (IVW: p = 0.01, OR: 0.74, 95% CI: 0.58-0.94) and 5-methylthioadenosine (IVW: p = 0.001, OR: 1.25, 95% CI: 1.09-1.44). Sensitivity analyses confirmed result robustness. MVMR analysis demonstrated direct effects of blood albumin, along with CSF metabolites such as alpha-hydroxyisocaproate, 1-ribosyl-imidazoleacetate, 5-methylthioadenosine, N1-methylinosine, and urate, independent of other factors.
conclusionsThis study reveals metabolite-brain tumor links, shows biomarker potential for screening and prevention, and offers new oncology insights for mechanisms and therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.